The Digital Source For China's Tech Innovation Since 2000

Week In Review: Two China Affiliated Biopharmas Raise $585 Million In IPOs Markets

November 7, 2021

Source:

News Snapshot:

LianBio raised $325 million in its Nasdaq IPO at a market capitalization of $1.9 billion to support its drug in-licensings for China. Beijing Clover Biopharma also completed a $260 million IPO in Hong Kong.

Go To Original Source →

Other Related News:

China Claims US CHIPS And Science Act Will Disrupt International Trade, Distort Global Semiconductor Supply Chains Global Online Money

August 11, 2022

A Look at the Electric Vehicle Transformation in China

August 11, 2022

Taiwan security officials want Foxconn to drop stake in Chinese chipmaker-FT

August 11, 2022

US accuses Chinese company of helping ZTE hide business with Iran

August 11, 2022

China Has Painted Itself Into a Semiconductor Corner

August 11, 2022

China Claims US CHIPS And Science Act Will Disrupt International Trade, Distort Global Semiconductor Supply Chains High Tech Info

August 11, 2022

Greater China startups record 33.5% yearly slump in deal value in Q2 as megadeals become scarce

August 11, 2022

UN trade body urges actions to curb cryptocurrencies in developing countries

August 11, 2022

?Parallel Markets?ASUS ZenFone 9 arrives in Hong Kong first, with the first asking price starting from 5,450!

August 11, 2022